Machine Learning & High Dimensional Data

– Clinical Outcome Prediction Using Bayesian Neural Networks with Fuzzy Logic Inferences

Advances in biostatistics and computing have led to the creation of novel types of machine learning algorithms for clinical outcome prediction models. Three clinically and statistically robust models include artificial neural networks, fuzzy logic and bayesian analysis. These techniques complement classical approaches of regression analysis and decision tree analysis. This editorial explains the novel outcome prediction system using Bayesian neural networks with fuzzy logic. This novel approach can be practically applied to both clinical and non-clinical settings.

Benjamin W. Y. Lo MD, Department of Neurological Surgery, Lenox Hill Hospital

Introduction to Bayesian Analysis, Artificial Neural Networks and Fuzzy Logic

Bayesian Analysis

Bayesian analysis enables incorporation of new data with existing knowledge. Based on this knowledge, the researcher expresses the degree of belief about a certain parameter in the form of a prior probability distribution. The normal bell-shaped distribution is an example of a probability distribution. This prior probability distribution is then combined with its likelihood of occurrence, forming a posterior probability distribution (posterior probability = prior probability X likelihood).

The end result of Bayesian analysis is the formation of a posterior probability distribution (Figure 1). It represents a revised or updated belief after taking new data into account. If there is lack of existing knowledge on the subject of interest, the researcher can still use Bayesian techniques. Here, the researcher is encouraged to use vague or uninformed prior probabilities.

Artificial Neural Networks

Artificial neural networks mimic biological neural systems. In biological systems, incoming dendrites collect signals which feed to the neuron (Figure 2). An electrical signal propagates along the axon with neurotransmitter discharge at the synapse. Examples of biological neural networks include the human brain and retina.

In artificial neural networks,input variables converge on a number of nodes. Nodes are grouped into layers. Layers are linked to each other via interconnection links. Between input and output layers, there can exist one or two hidden layers (Figure 3). Latent variables make up the hidden layer(s). In order to advance from one layer to the next, signals are processed via activation functions.

Artificial neural networks assume all or none logic. In the case of clinical outcome prediction, subjects are classified as having good or bad prognosis. Within each layer, nodes in the artificial neural network are connected with each other via connection links. Activation functions and associated weights are applied to these connection links. Artificial neural networks are intelligent systems that can learn and change behaviour by themselves as they gain experience. They also take into account latent variables or unobserved variables. These variables are not directly measured or accounted for during the design of the artificial neural network.

Fuzzy Logic

Fuzzy logic allows for uncertainty in disease diagnosis and prognosis. Fuzzy logic functions can carry any value from 0 to 1 (Figure 4). It, therefore, recognizes grey zones in diagnosis and prognosis, and registers diseases along a severity spectrum from mild to severe. One of the advantages of fuzzy logic is its explicit knowledge representation. The individual using fuzzy logic can:

1. specify inputs, control actions and outputs, and

2. clarify, or defuzzify, the entire process by adding crisp control actions, such as cutoff levels for diagnoses and prognoses, as well as trigger threshold levels for treatment.

By doing do, all actions in fuzzy logic can be accounted for (process of verification). Optimization is also achievable to create efficient fuzzy logic systems. Unlike artificial neural networks where learning is done by the networks themselves as they gain experience from datasets, fuzzy logic systems cannot train themselves. The designer derives all action commands manually in the form of “if-then” rules. The final fuzzy logic system can be represented in various ways, including equation or conceptual diagram formats.

Bayesian Neural Networks with Fuzzy Logic Inferences

A multilayer perceptron artificial neural networks model is illustrated in Figure 5, where the output as follows:

In the Bayesian approach to artificial neural networks, the goal is to find the predictive distribution for target values in the new test case/model, given inputs for that case and inputs/targets in training cases. Here, the probability of data according to a particular model is an integral, representing the summation of all possible parameter values weighted by the strength of belief (as assigned by the researcher) in these parameter values. In a Bayesian neural network, the posterior probability density is proportional to the product of prior probability density and its associated likelihood, where the likelihood is the product of probabilities of data given parameters (weights and biases).

Principles of fuzzy logic, as discussed above, can then be applied to Bayesian neural networks. Here, all actions (verification) in fuzzy logic are accounted for, and optimization is achievable. Bayesian neural networks with fuzzy logic inferences can be represented as follows:

Expected outcome of function (fuzzyBayesian neural network)

= defuzzification technique applied to a Bayesian neural network where defuzz can be max-min, centroid, left of mean, right of mean, or another defuzzification crisp control action rule.

Bayesian neural networks with fuzzy logic inferences can be applied to both clinical and non-clinical systems. In clinical outcome prediction using high dimensional data, Bayesian neural networks can be conceptually summarized as follows: Based on one’s own experience, one can specify (fuzzy logic) where along a spectrum of probabilities (provided by the Bayesian neural networks) the outcome lies. If the outcome falls outside the spectrum in real case scenario, the researcher is then encouraged to investigate unknown elements (latent variables) influencing the outcome variable in question.

Conclusion

Bayesian neural networks with fuzzy logic can be applied to both clinical and non-clinical settings. In clinical outcome prediction, it makes use of existing knowledge, recognizes unknown areas, incorporates one’s clinical reasoning and experience, as well as compensates for uncertainty in prognostication.

Acknowledgement

Illustrations are provided by medical illustrator, Aurora W.M. Lo, B.Com (Toronto) CPA (Illinois).

and

His focus is cerebrovascular disorders. His research focus characterizes brainbody interactions in Neurocritical care patients with cerebrovascular disorders. Dr. Lo’s qualifications include FRCSC certification in Neurosurgery (2009), FRCSC certification in critical care medicine (2011), and MSc and PhD degrees in clinical epidemiology and biostatistics from McMaster University, Canada. His clinical experience includes working as a neurosurgeon and neuroICU specialist at St. Michael’s Hospital, University of Toronto; Montreal Neurological Institute & Hospital, McGill University; and Northwell Health Lenox Hill Hospital, Manhattan, New York.

Machine Learning for Healthcare

August 11-12th, 2023

New York City, New York https://www.mlforhc.org/

About Event: MLHC is an annual research meeting that exists to bring together two usually insular disciplines: computer scientists with artificial intelligence, machine learning, and big data expertise, and clinicians/medical researchers.

Listed Under: Information Technology

4th Edition of International Precision Medicine Conference

August 17-19, 2023

Online Event https://precision-medicine.magnusconferences. com/index.php

About Event: Precision medicine is a brand-new approach to illness treatment and prevention. Precision medicine strives to establish a personalized and unique treatment and preventative regimen for each patient based on their entire medical profile, including genetic data, medical history, environmental factors, and even lifestyle. The design of a one-of-a-kind treatment necessitates access to almost all of an individual's specific medical data.

Listed Under: Medical Sciences

ESC Congress 2023

August 25-28, 2023

Amsterdam - Netherlands https://www.escardio.org/Congresses-Events/ESCCongress

About Event: SC Congress you will have the opportunity to connect, gain new perspectives, and create synergies with the global cardiology community. It really is four days that matter. Wherever you are in the world, whatever your role in supporting patients that face cardiovascular disease, we hope you will join forces with us in Amsterdam, or online. Together we can make a difference.

Listed Under: Medical Sciences

International Conference on Advanced General Surgery and Oncology

September 04, 2023

Dusseldorf, Germany https://www.sciencecite.com/event/index. php?id=2093912

About Event: International Conference on Advanced General Surgery and Oncology Is a platform with all the field's leading scientists, outstanding researchers, academic people, and industrialists from national and international locations.

Listed Under: Surgical Specialty

International Conference on Neurology and Health Care

September 05, 2023

Hamburg, Germany https://iiter.org/conf/index.php?id=2085891#

About Event: International Conference on Neurology and Health Care ICNHC. This phenomenal event will see some of the biggest names in the world of technology and engineering uniting together on the same platform for one goal - accelerating technological development through improved learning, research propagation, skill development and networking.

Listed Under: Medical Sciences

International Congress on Neuromuscular Diseases

September 25th-26th, 2023

Hamburg, Germany

About Event: International Congress on Neuromuscular Diseases (ICNEDI-23), will welcome leading scientists, practitioners, and academicians from the field or concerning the field on one platform. https://www.wrfconference.com/event/index. php?id=2035532

Listed Under: Medical Sciences

International Conference on Health Information Technology and Healthcare Efficiency

October 03, 2023

Hamburg, Germany

About Event: International Conference on Health Information Technology and Healthcare Efficiency is a platform with all the field's leading scientists, outstanding researchers, academic people, and industrialists from national and international locations. https://www.sciencecite.com/event/index. php?id=2094233

Listed Under: Technology, Equipment’s & Devices

International Conference on Neurology and Brain Disorders

Intelligent Health

13-14 September, 2023

Basel, Switzerland https://intelligenthealth.ai/

About Event: Intelligent Health is THE only largescale, global summit that purely focuses on AI in healthcare and brings together the world’s brightest AI health brains from pharmaceutical, biotech, medtech, health provisions, clinicians, tech companies, startups, investment, and science to advance discussions on how to apply AI and drive technological collaboration in healthcare.

Listed Under: Information Technology

October 19 -21, 2023

Boston, Massachusetts, USA https://neurologycongress.com/

About Event: The conference will enlighten the theme “BRAIN: Bolstering & Renovating Advanced techniques In Neurology” and will focus on its agenda to bring together distinguished scientists, researchers, academicians, notable neurologist, healthcare professionals, surgeons, nurses, caregivers, pharmacists, industry icons and government representatives to discuss the latest innovations, trends, and problems in the field.

Listed Under: Medical Sciences

Stryker's Novel Innovation for Orthopedic Surgeries

Stryker has introduced the Ortho Q Guidance system, a cutting-edge solution that empowers surgeons to achieve advanced surgical planning and guidance during hip and knee procedures.

With convenient control accessible from the sterile field, the system integrates a redesigned, state-of-theart camera for enhanced optical tracking, coupled with sophisticated algorithms provided by the newly launched Ortho Guidance software.

This powerful combination equips surgeons with additional capabilities for surgical planning and guidance.

When utilized alongside Ortho Q, the Ortho Guidance software (specifically designed for Express Knee, Precision Knee, and Versatile Hip) acts as a comprehensive planning and intraoperative guidance system, optimizing procedural efficiency and speed through an intelligent and streamlined workflow.

The Ortho Q Guidance system encompasses notable features:

• The Implant agnostic software is compatible with various implants, enabling surgeons to utilize their preferred choice and granting facilities the flexibility to cater to diverse service line requirements within a single platform.

• Dedicated software for Triathlon implants provides surgeons with valuable clinical feedback, further enhancing their surgical experience.

• The system's compact design allows for seamless integration both in the operating room and the ambulatory surgical center (ASC) setting.

Shimadzu Medical Unveils

Next-Gen Glass-Free Flat Panel Detectors

Shimadzu Medical Systems USA, a Shimadzu Corporation subsidiary, has introduced new V series Glass-Free Flat Panel Detectors (FPD) that are now compatible with its general radiography systems.

With the introduction of the Glass-Free FPDs, the company’s V series lineup is now complete, providing comprehensive support for diverse imaging needs.

Featuring an ultra-fine 99-micron small pixel pitch, these detectors excel at capturing intricate details in X-ray images.

Furthermore, their lightweight design not only reduces the physical strain on radiology technologists but also enhances durability, offering increased resilience against accidental drops. To address the healthcare worker shortage and meet the demands of medical facilities, Shimadzu is proud to introduce the V series Glass-Free Flat Panel Detectors (FPDs).

Available in three sizes (17"x17", 14"x17",and 10"x12"), these state-of-the-art detectors are compatible with its RADspeed Pro style edition V series and MobileDaRt Evolution MX8 V type systems.

By continuously enhancing our digital radiography system lineup, the company aims to provide comprehensive solutions that cater to the diverse needs of clinical environments.

Read the complete post

Read the complete post

Abbott Launches World's First Breakthrough Dual Chamber Leadless Pacemaker

Abbott has achieved a groundbreaking milestone with the launch of AVEIR™, the world's first dual-chamber leadless pacemaker system designed to address abnormal or slow heart rhythms.

This breakthrough device has received approval from the U.S. Food and Drug Administration, paving the way for expanded access to leadless pacing for millions of individuals across the United States. With over 80% of pacemaker recipients requiring pacing in both the right atrium and right ventricle, this innovative system revolutionizes treatment options.

The AVEIR DR pacemaker system incorporates Abbott's proprietary i2i™ communication technology, enabling synchronized or coordinated cardiac pacing between two leadless pacemakers based on each person's clinical needs.

Through the utilization of high-frequency pulses transmitted via the body's naturally conductive blood characteristics, i2i technology facilitates seamless communication between the paired, co-implanted devices.

This conductive communication is vital, as it consumes significantly less battery power compared to inductive, radio frequency, or Bluetooth® communication methods commonly used in traditional pacemakers or implantable medical devices.

With a compact size of approximately one-tenth that of a traditional pacemaker, the AVEIR DR leadless pacing system consists of two devices: the previouslyapproved AVEIR VR single chamber device for pacing the right ventricle, and the newly-approved AVEIR AR single chamber device for pacing the right atrium.

The AVEIR DR system incorporates Abbott's novel i2i technology, overcoming engineering challenges by enabling beat-to-beat communication between the two leadless pacemakers.

Clarius, Usono Launch Groundbreaking Wireless Wearable Imaging Solution

Clarius Mobile Health, a renowned provider of highdefinition handheld ultrasound systems, and Usono, an innovative developer of ultrasound accessories, have joined forces at the ECSS Paris 2023 congress to introduce an unprecedented wireless and wearable ultrasound imaging solution.

This groundbreaking technology caters to researchers studying human anatomy in motion.

The wearable ultrasound solution combines the Clarius HD3 high-definition wireless ultrasound scanner with research software and Usono's ProbeFix Dynamic, enabling hands-free, stable, and reproducible ultrasound imaging during exercise and other activities that involve crucial motion and continuous scanning.

This innovation marks the first wireless dynamic ultrasound imaging solution designed specifically for researchers in the fields of sports medicine, rehabilitation, and related areas.

Clarius ultrasound tools for research provide researchers with access to internally collect raw data, gyroscope collection, a programmable interface, and custom software for real-time analysis anywhere, ensuring a comprehensive and flexible research experience.

In contrast to traditional pacemakers, leadless devices are implanted directly into the heart using minimally invasive procedures, eliminating the need for cardiac leads. As a result, leadless pacemakers minimize Read the complete post

Read the complete post potential complications associated with leads and infections, while also offering a shorter and less restrictive recovery period following implantation.

Dexcom G7 Next-Generation Continuous Glucose Monitoring System Launched

In a significant development, Dexcom, Inc. has officially announced that the next-generation Dexcom G7 Continuous Glucose Monitoring System has received approval from Health Canada.

This groundbreaking system is now available for individuals of all ages, starting from two years old, who are managing diabetes.

With over 3 million Canadians affected by the complex and burdensome condition of diabetes, the importance of managing glucose levels and making daily treatment decisions cannot be overstated.

However, the recent approval of Dexcom G7 by Health Canada brings a game-changing technology that promises to ease the management of diabetes for Canadians.

This revolutionary system has demonstrated its potential to reduce hospitalizations and emergency room visits related to hypoglycemia by an impressive 42 percent*.

By granting access to Dexcom G7, Health Canada empowers individuals with a tool that enhances their diabetes management and potentially improves their overall well-being.

Dexcom G7 revolutionizes diabetes management by offering users a powerful yet simple solution that empowers them to gain better control over their condition.

This innovative system features a low-profile, all-inone sensor and transmitter that warms up in record time, surpassing any other CGM available on the market†,5. With Dexcom G7, users can effortlessly access realtime glucose readings, which are automatically transmitted to their compatible smart device‡ or receiver, eliminating the need for routine scanning or finger pricking.

The system includes a range of customizable alerts, including predictive urgent low alerts that help prevent potentially dangerous hypoglycemic events and enable users to spend more time within their target glucose range**,2,3,4.

Dexcom G7 also facilitates seamless information sharing with family, loved ones, and healthcare teams through cutting-edge remote monitoring and reporting capabilities††, ensuring support and collaboration anytime and anywhere.

Dexcom G7 introduces a range of new features and enhancements that take diabetes management to the next level:

• Unprecedented Size: The Dexcom G7 sensor is the smallest ever, being 60% smaller than the Dexcom G6. It offers multiple approved wear locations, ensuring a comfortable and discreet experience‡‡.

• Streamlined Design: With the all-in-one sensor and transmitter, Dexcom G7 simplifies the entire CGM system, making it more user-friendly and convenient.

• Swift Sensor Warm-Up: Dexcom G7 boasts a remarkable 30-minute warm-up time, which is twice as fast as any other CGM available. This quick start allows for a seamless and hassle-free experience.

• Extended Grace Period: Users now have a generous 12-hour grace period to replace finished sensors, providing greater flexibility and convenience during transitions between sensor sessions.

• Enhanced Alert Customization: Dexcom G7 offers improved alert customization, catering to individual user needs and preferences. This allows for a more personalized and tailored experience.

• Redesigned Mobile App: The mobile app accompanying Dexcom G7 has been redesigned and simplified, providing a user-friendly interface. Integration with Dexcom Clarity§§ ensures seamless data analysis and reporting for users.

These new features and enhancements with Dexcom G7 redefine diabetes management, offering users unmatched comfort, flexibility, and control over their condition.

Read the complete post

Baxter Introduces Advanced ICU Bed for Enhanced Patient Care and Recovery

Baxter International Inc has introduced advanced ICU bed, Hillrom Progressa+ in the United States. This new bed incorporates advanced technology and features that aim to facilitate patient care and aid in their recovery process.

The Progressa+ bed offers a range of technologies specifically designed to address pulmonary needs, ensure skin protection, and support early mobility protocols.

USMI Unveils Cutting-Edge Robotic Surgery Device Enhanced Surgical Precision

US Medical Innovations, LLC (USMI) has unveiled the Canady Flex RoboWrist™, a cutting-edge robotic surgery device designed for both open and laparoscopic procedures in the United States.

With its existing approval and successful utilization in the Middle East, Europe, and Asia, this innovative device has already made a significant impact worldwide.

The Canady Flex RoboWrist is a handheld surgical instrument with full articulation and motorization, featuring a range of end effectors such as a hook, scissors, needle driver, and dissector.

It offers three degrees of freedom and an impressive 360 degrees of rotation. The device is compatible with the USMI XL-1000 electrosurgical generator, providing the option of utilizing the mono scissors or hook for electrosurgery.

To support pulmonary health, the bed provides in-bed percussion, vibration, and continual lateral rotation therapies. These therapies are intended to reduce complications associated with immobility and promote better respiratory outcomes. Additionally, the improved bed frame allows for easier access to the head of the bed, facilitating procedures like intubation.

In terms of skin protection, the Progressa+ bed is equipped with enhanced support surfaces that promote optimal skin health and wound healing. The inclusion of a new top cover makes cleaning easier, enhancing hygiene and infection control measures.

Another notable feature of the Progressa+ bed is its support for early patient mobility. By integrating an advanced lift system, the bed enables the care team to facilitate patient mobility protocols while minimizing the risk of injury for clinicians. The one-button FullChair function, along with sit-to-stand Chair Egress, assists clinicians in safely and easily moving patients.

The Progressa+ bed is currently available in the United States, and Baxter has plans to launch it in additional markets worldwide over the next 18 months. It is part of Baxter's comprehensive portfolio of beds and surfaces tailored to meet the diverse needs of care environments.

Read the complete post

The primary purpose of the Flex RoboWrist is to facilitate tissue dissection, transection, and suturing during various surgical procedures. It excels in open, endoscopic, and minimally invasive surgeries, including laparoscopic, urologic, gynecologic, general, and thoracic procedures.

This remarkable device boasts exceptional precision, enabling surgeons to perform intricate procedures with unparalleled accuracy. By employing advanced robotic technology, the Flex RoboWrist ensures precise movements, thereby reducing the risk of human error and enhancing overall surgical outcomes.

With state-of-the-art automation and intelligent control systems, the device optimizes surgical workflows, saving valuable time in the operating room. Surgeons can now focus more on critical decisionmaking, while the Flex RoboWrist handles repetitive tasks, ultimately improving efficiency.

In addition to its impressive functionality, the Canady Flex RoboWrist is a cost-effective solution. It can be autoclaved up to 50 times, eliminating the need for disposables and providing significant savings. This feature, coupled with its exceptional durability, contributes to its overall cost-effectiveness and sustainability.

Read the complete post

Grow your audience with increased reach, impact and user-friendliness

Rise above geographical boundaries

Generate new business

Gain the strong web presence differentiating yourself from competitors

Connect and engage with your target audience

Give more exposure to industry specific people

Increase your brand profile and share your capabilities with leading industry professionals